Claudia Menzaghi
Overview
Explore the profile of Claudia Menzaghi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
917
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Valenzano M, Peduto A, Comba A, Menzaghi C, Trischitta V
Acta Diabetol
. 2024 Oct;
62(1):135-138.
PMID: 39441403
No abstract available.
2.
Menzaghi C, Marucci A, Mastroianno M, Di Ciaccia G, Armillotta M, Prehn C, et al.
J Clin Endocrinol Metab
. 2024 Aug;
PMID: 39193712
Objective: To study whether inflammation is associated with and helps predict mortality risk in patients with type 2 diabetes. To explore the intertwined link between inflammation and tryptophan metabolism on...
3.
Marucci A, Menzaghi C, Dodesini A, Albizzi M, Acquafredda A, Fini G, et al.
Acta Diabetol
. 2024 Aug;
62(3):323-328.
PMID: 39190183
Aims: Monogenic diabetes is one of the few examples in metabolic diseases in which a real precision medicine approach can be implemented in daily clinical work. Unfortunately, most of what...
4.
Lamacchia O, Menzaghi C, Copetti M, Mastroianno M, Corsano C, Prehn C, et al.
J Clin Endocrinol Metab
. 2024 Aug;
PMID: 39136240
Context: The independent role of glomerular filtration rate (GFR) decline in shaping the risk of mortality in people with type 2 diabetes has only been partially addressed. Objective: The objective...
5.
Trischitta V, Antonucci A, Adamski J, Prehn C, Menzaghi C, Marucci A, et al.
Acta Diabetol
. 2024 Aug;
61(8):1015.
PMID: 39115727
No abstract available.
6.
Trischitta V, Antonucci A, Adamski J, Prehn C, Menzaghi C, Marucci A, et al.
Acta Diabetol
. 2024 Apr;
61(8):1007-1013.
PMID: 38627282
Aims: Aim of this study was to investigate in type 2 diabetes whether expression level of GALNT2, a positive modulator of insulin sensitivity, is associated with a metabolic signature. Methods:...
7.
Trischitta V, Mastroianno M, Scarale M, Prehn C, Salvemini L, Fontana A, et al.
BMJ Open Diabetes Res Care
. 2023 Sep;
11(5).
PMID: 37734903
Introduction: Low glomerular filtration rate (GFR) is a leading cause of reduced lifespan in type 2 diabetes. Unravelling biomarkers capable to identify high-risk patients can help tackle this burden. We...
8.
Trischitta V, Menzaghi C, Copetti M
Diabetes
. 2023 Jul;
72(8):1057-1059.
PMID: 37471601
No abstract available.
9.
Paola R, Marucci A, Mangiacotti D, Antonucci A, Fontana A, Wang X, et al.
Adv Biol (Weinh)
. 2023 Mar;
7(9):e2200319.
PMID: 36861373
Several studies have shown that downregulation of GALNT2 (Polypeptide N-Acetylgalactosaminyltransferase 2), encoding polypeptide N-acetylgalactosaminyltransferase 2, decreases high-density lipoprotein cholesterol (HDL-C) and increases triglycerides levels by glycosylating key enzymes of lipid...
10.
Marucci A, Paola R, Rutigliano I, Fini G, Pezzilli S, Menzaghi C, et al.
Acta Diabetol
. 2023 Jan;
60(3):459.
PMID: 36707440
No abstract available.